Via interaction with CD31, high levels of CD38 may lead to increased adhesion to stromal cells, maintaining MM cells in the immunosuppressive microenvironment of the bone marrow, but also potentially reducing the risk of extramedullary disease. Here, PECAM1 is linked to Miyoshi myopathy.